GET THE APP

A Study to Investigate the Influential Factors to the Adoption of Pharma 4.0 within the Pharmaceutical Supply chain
..

Journal of Biomedical and Pharmaceutical Sciences

ISSN: 2952-8100

Open Access

A Study to Investigate the Influential Factors to the Adoption of Pharma 4.0 within the Pharmaceutical Supply chain


15th International Conference on Pharmaceutical Education and Practice

August 10-11, 2023 | Webinar

Ashish A. Adhikari

SP Jain School of Global Management, India

Posters & Accepted Abstracts: J Biomed Pharm Sci

Abstract :

The world is moving towards digitization and pharmaceutical companies are actively preparing for this change transition. Some pharma organizations have managed this change well, however most others have been left out. Implementation of digitization is a complex process involving multiple factors, stakeholders and constraints. Digitization or Industry 4.0 as it is popularly called, promises many benefits to the Pharmaceutical Supply Chain. Industry 4.0 within the Pharma context is called as P4.0. However, the nature of the Pharma industry and its impact on patient safety provides unique challenges to Digital implementations. Most Pharmaceutical companies rush into P4.0 considering it as the “Flavor of the season”. This can result into failures and stalling of the change process. A deeper understanding of the drivers and influencers to digitization is needed before proceeding for any such implementations. This paper presents a study on the various independent variables that influence and impact the successful adoption of digitization in pharmaceutical companies, within the supply chain. A gap analysis from literature survey of more than 250 articles from 2013 – 2021 has helped to identify six independent variables that may influence the adoption of P4.0 within the supply chain. These six independent variables are Leadership drive, Organizational culture, Digital capability, Data availability, Data security and Regulatory acceptance. The impact of these independent variables on adoption is measured in the form of research outcomes identified within the literature survey. These outcomes are Reduced costs, Higher efficiencies, Reduced lead times, Reduced breakdowns, Higher quality and Improved human capability.

Biography :

Ashish is a Senior Advisor at Mckinsey and Co. based out of Mumbai, India. His responsibilities are to streamline Manufacturing Operations for the Pharmaceutical Supply chain. His strong passion and expertise has been around leading teams and organizations towards Continuous improvement and Change management. His experience of working across different Industries and geographies has developed strong cultural sensitivity, process appreciation and execution skills. He is also a Research Scholar with a Doctorate in Business administration from SP Jain School of Global Management, Sydney campus. His Research interests include Change management and understanding the challenges of Pharma 4.0 adoption across the supply chain.

arrow_upward arrow_upward